159 related articles for article (PubMed ID: 15655740)
21. Emergence of high-level fluoroquinolone-resistant Streptococcus pneumoniae in Turkey.
Ak O O; Benzonana N; Ozer S; Eraksoy H
Int J Infect Dis; 2003 Dec; 7(4):288-9. PubMed ID: 14656422
[No Abstract] [Full Text] [Related]
22. Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates.
Adam HJ; Schurek KN; Decorby MR; Weshnoweski B; Vashisht R; Karlowsky K; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2006 Jul; 58(1):202-4. PubMed ID: 16636082
[TBL] [Abstract][Full Text] [Related]
23. Streptococcus pneumoniae clinical isolate highly resistant to fluoroquinolones in a child.
Huang TD; Avrain L; de Bilderling G; Glupczynski Y
Pediatr Infect Dis J; 2006 Dec; 25(12):1195-6. PubMed ID: 17133175
[No Abstract] [Full Text] [Related]
24. Fluoroquinolone-resistant Streptococcus pneumoniae.
Pletz MW; Fugit RV; McGee L; Glasheen JJ; Keller DL; Welte T; Klugman KP
Emerg Infect Dis; 2006 Sep; 12(9):1462-3. PubMed ID: 17073107
[No Abstract] [Full Text] [Related]
25. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia.
Balkhy HH; Memish ZA; Shibl A; Elbashier A; Osoba A
East Mediterr Health J; 2005; 11(1-2):36-44. PubMed ID: 16532669
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
Jacobs MR
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility and bactericidal activity of 8 oral quinolones against conventional-fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
Yokota S; Ohkoshi Y; Fujii N
Diagn Microbiol Infect Dis; 2009 Sep; 65(1):76-80. PubMed ID: 19679241
[TBL] [Abstract][Full Text] [Related]
28. Pneumococcal resistance in the postvaccine era.
Temime L; Guillemot D; Boëlle PY
Pediatr Infect Dis J; 2006 Apr; 25(4):382-3. PubMed ID: 16568001
[No Abstract] [Full Text] [Related]
29. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003).
Johnson DM; Stilwell MG; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):69-74. PubMed ID: 16546341
[TBL] [Abstract][Full Text] [Related]
30. Increase of the M phenotype among erythromycin-resistant Streptococcus pneumoniae isolates from Spain related to the serotype 14 variant of the Spain9V-3 clone.
Ardanuy C; Fenoll A; Berrón S; Calatayud L; Liñares J
Antimicrob Agents Chemother; 2006 Sep; 50(9):3162-5. PubMed ID: 16940119
[TBL] [Abstract][Full Text] [Related]
31. Fluoroquinolone resistance in Streptococcus pneumoniae.
Peterson DE; Sahm DF
N Engl J Med; 1999 Nov; 341(20):1547; author reply 1547-8. PubMed ID: 10577110
[No Abstract] [Full Text] [Related]
32. Use of antibiotics and penicillin-resistant pneumococci: what can we learn from Iceland?
Lous J
Otolaryngol Head Neck Surg; 2007 Aug; 137(2):192-4. PubMed ID: 17666239
[TBL] [Abstract][Full Text] [Related]
33. Multiply resistant Streptococcus pneumoniae infection.
Byrnes P
Med J Aust; 1993 Sep; 159(6):427-8. PubMed ID: 8377702
[No Abstract] [Full Text] [Related]
34. Erythromycin resistance caused by erm(A) subclass erm(TR) in a Danish invasive pneumococcal isolate: are erm(A) pneumococcal isolates overlooked?
Lambertsen L; Ekelund K; Hansen DS; Kaltoft M; Christensen JJ; Hammerum AM
Scand J Infect Dis; 2008; 40(6-7):584-7. PubMed ID: 18584554
[TBL] [Abstract][Full Text] [Related]
35. Resistance of S. pneumoniae to fluoroquinolines--US, 1995-1999.
Ann Pharmacother; 2001 Nov; 35(11):1509. PubMed ID: 11724112
[No Abstract] [Full Text] [Related]
36. Assessment of pharmacokinetic-pharmacodynamic target attainment of gemifloxacin against Streptococcus pneumoniae.
Owens RC; Bhavnani SM; Ambrose PG
Diagn Microbiol Infect Dis; 2005 Jan; 51(1):45-9. PubMed ID: 15629228
[TBL] [Abstract][Full Text] [Related]
37. [Resistant pneumococci].
Garau J; Liñares J
Med Clin (Barc); 1985 May; 84(17):688-90. PubMed ID: 4010372
[No Abstract] [Full Text] [Related]
38. Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolones.
Huelves L; Sevillano D; Martínez-Marín C; López-Casla MT; Gracia M; Alou L; del Carmen Ponte M; Prieto J; Soriano F;
Int J Antimicrob Agents; 2006 Apr; 27(4):294-9. PubMed ID: 16527462
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?
Doern GV; Richter SS; Miller A; Miller N; Rice C; Heilmann K; Beekmann S
Clin Infect Dis; 2005 Jul; 41(2):139-48. PubMed ID: 15983908
[TBL] [Abstract][Full Text] [Related]
40. [Antibiotic-resistant pneumococci. 2 case report].
Hebert JP; Caillet R
Nouv Presse Med; 1980 Mar; 9(15):1098-9. PubMed ID: 7465382
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
